Issue 1/2010
Special Issue: Lung Cancer; Guest Editor: Adi Gazdar
Content (18 Articles)
Natural history of bronchial preinvasive lesions
Taichiro Ishizumi, Annette McWilliams, Calum MacAulay, Adi Gazdar, Stephen Lam
Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation
Kenichi Suda, Kenji Tomizawa, Tetsuya Mitsudomi
Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy
James P. Sullivan, John D. Minna, Jerry W. Shay
Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer
Raj Chari, Kelsie L. Thu, Ian M. Wilson, William W. Lockwood, Kim M. Lonergan, Bradley P. Coe, Chad A. Malloff, Adi F. Gazdar, Stephen Lam, Cathie Garnis, Calum E. MacAulay, Carlos E. Alvarez, Wan L. Lam
Lung cancer: From single-gene methylation to methylome profiling
Gerwin Heller, Christoph C. Zielinski, Sabine Zöchbauer-Müller
Modeling prostate cancer: a perspective on transgenic mouse models
Varinder Jeet, Pamela J. Russell, Aparajita Khatri
The role of MAP kinases and MAP kinase phosphatase-1 in resistance to breast cancer treatment
Kelly K. Haagenson, Gen Sheng Wu
Targeted therapy for gastrointestinal stromal tumors: current status and future perspectives
Georgios S. Papaetis, Kostas N. Syrigos
Cetuximab in combination therapy: from bench to clinic
David E. Gerber, Hak Choy
DNA methylation markers in colorectal cancer
Myoung Sook Kim, Juna Lee, David Sidransky
p66Shc—a longevity redox protein in human prostate cancer progression and metastasis
Mythilypriya Rajendran, Paul Thomes, Li Zhang, Suresh Veeramani, Ming-Fong Lin
Important role of integrins in the cancer biology
R. Rathinam, Suresh K. Alahari